Quick Answer
Pelthos Therapeutics Inc. reported Total Assets of $130.40 million for the year ending 2025.
- Pelthos Therapeutics Inc. showed an increase of +9,425.0% in Total Assets from 2024 to 2025.
- This data is from Pelthos Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $4.03 million | Q2 2024: $2.60 million | Q3 2024: $2.14 million | Q1 2025: $911.2 thousand | Q2 2025: $822.9 thousand | Q3 2025: $126.43 million.
- Over the full 4 years of available data (2022 to 2025), Pelthos Therapeutics Inc.'s Total Assets has grown by 236,666.9%.
- Historical annual values: Fiscal year 2025: $130.40 million | Fiscal year 2024: $1.37 million | Fiscal year 2023: $96.4 thousand | Fiscal year 2022: $55.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: